Balstilimab
- Generic Name
- Balstilimab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2148321-77-9
- Unique Ingredient Identifier
- 1Q2QT5M7EO
- Associated Conditions
- -
- Associated Therapies
- -
A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Agenus Inc.
- Registration Number
- NCT05033132
- Locations
- 🇨🇳
Betta Clinical Study Site 27, Wuhu, Anhui, China
🇨🇳Betta Clinical Study Site 10, Zhanjiang, Guangdong, China
🇨🇳Betta Clinical Study Site 43, Wuhan, Hubei, China
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Conditions
- Interventions
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2024-08-21
- Target Recruit Count
- 36
- Registration Number
- NCT04943848
- Locations
- 🇺🇸
Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, United States
🇺🇸Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸Children's Health Orange County (CHOC), Orange, California, United States
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
- Conditions
- Interventions
- First Posted Date
- 2019-07-22
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 28
- Registration Number
- NCT04028063
- Locations
- 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Agenus Inc.
- Target Recruit Count
- 550
- Registration Number
- NCT03860272
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
🇺🇸Providence Portland Cancer Center, Portland, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.